VRTX Related Trading Halts
-
Vertex Pharmaceuticals (VRTX) To Resume Trading at 7:20AM
-
Shares of Vertex Pharma (VRTX) resume trading down almost 17%
-
Vertex Pharma (VRTX) shares resume trading up 30%
-
Shares of Vertex (VRTX) to resume trading at 7:50am ET
-
Vertex Pharma (VRTX) Reports Statistically Significant Data from VX-809 and KALYDECO Phase 2 in Lung Function
-
Vertex Pharma (VRTX) trading halted with news pending
-
Shares of Vertex Pharma (VRTX) resume trading up 1% (up 9% for the session)
-
Shares of Vertex Pharma (VRTX) to resume trading at 1:35pm ET
-
Vertex (VRTX) Shares Halted with News Pending Following Confirmation of FDA Approval of KALYDECO
-
Vertex (VRTX) shares resume trading up 2%
-
Vertex (VRTX) will resume trading at 4:50PM
-
FDA Panel Backs Vertex Pharmaceuticals (VRTX) Telaprevir
-
Vertex (VRTX) shares have been halted as an FDA advisory panel will review its telaprevir NDA today
Back to VRTX Stock Lookup
